Treatments

The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.

You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.

Become a Partner.

Country Product Indication Sponsor Date
Liposomal amphotericin B Visceral leishmaniasis Fujisawa USA, Inc.;3 Parkway North Center;Deerfield, Illinois, 60015 December 6, 1996
Monoclonal antibody-B43.13 Ovarian epithelial cancer Quest PharmaTech, Inc.;9407 20 Avenue, Edmonton, Alberta T6N 1E5; November 25, 1996
Somatropin for injection Growth hormone deficiency Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 November 18, 1996
Imexon Multiple myeloma AmpliMed Corporation;2321 Camino La Zorrela;Tucson, Arizona, 85718 November 8, 1996
Filgrastim Reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia Amgen, Inc.;One Amgen Center Dr.;Thousand Oaks, California, 91320 November 7, 1996
Ibuprofen i.v. solution Patent ductus arteriosus Farmacon-IL, LLC;1720 Post Road East, Suite 213;Westport, Connecticut, 06880 October 29, 1996
Ibuprofen lysine Patent ductus arteriosus Lundbeck, Inc.;Four Parkway North;Deerfield, Illinois, 60015 October 29, 1996
Leflunomide Prevention of acute and chronic rejection in patients who have received solid organ transplants Williams, MD, James W.;Rush-Presbyterian-St. Luke's Medical Ctr., Dept. o, 1653 West Congress Parkway;Chicago, Illinois, 60612 October 18, 1996
Riluzole Huntington disease Rhone-Poulenc Rorer Pharmaceuticals, Inc.;500 Arcola Road, PO Box 5096;Collegeville, Pennsylvania, 19426 October 15, 1996
Interferon gamma-1b Delaying time to disease progression in patients with severe, malignant osteopetrosis Horizon Pharma Ireland Limited;Connaught House, 1st Floor, 1 Burlington Road;Dublin 4 September 30, 1996
Amphotericin B lipid complex Invasive sporotrichosis The Liposome Company, Inc.;One Research Way;Princeton, New Jersey, 08540 September 23, 1996
9-nitro-20-(S)-camptothecin Pancreatic cancer SuperGen, Inc.;Two Annabel Lane, Suite 220;San Ramon, California, 94583 September 16, 1996
Aldesleukin Metastatic melanoma Chiron Corporation;4560 Horton St.;Emeryville, California, 94608 September 10, 1996
Prostaglandin E1 in lipid emulsion Ischemic ulceration of the lower limbs due to peripheral arterial disease Alpha Therapeutic Corporation;5555 Valley Boulevard;Los Angeles, California, 90032 September 10, 1996
Human acid precursor alpha-glucosidase, recombinant Glycogen storage disease type II Pharming/Genzyme LLC;c/o Genzyme Corporation, 1 Mountain Rd.;Framingham, Massachusetts, 01701 September 10, 1996
2′-deoxycytidine As a host-protective agent in the treatment of acute myelogenous leukemia Grant, Steven M.D.;Massey Cancer Center, VCU, P.O. Box 980230;Richmond, Virginia, 23298 September 9, 1996
Denileukin diftitox Cutaneous T-cell lymphoma Eisai, Inc.;300 Tice Boulevard;Woodcliff Lake, New Jersey, 07677 August 21, 1996
C1 esterase inhibitor (human) Treatment and prevention of angioedema caused by C1-esterase inhibitor deficiency Alpha Therapeutic Corporation;5555 Valley Boulevard;Los Angeles, California, 90032 August 21, 1996
Mitoxantrone Hormone refractory prostate cancer Serono;One Technology Place;Rockland, Massachusetts, 02370 August 21, 1996
Methionine/L-methionine AIDS myelopathy Genopia USA, Inc.;90 Gold Street, 6N;New York, New York, 10038 August 21, 1996
Amphotericin B lipid complex Invasive protothecosis The Liposome Company, Inc.;One Research Way;Princeton, New Jersey, 08540 August 21, 1996
Lucinactant Meconium aspiration syndrome Windtree Therapeutics, Inc.;2600 Kelly Road, Suite 100;Warrington, Pennsylvania, 18976 July 30, 1996
L-2-oxothiazolidine-4-carboxylic acid Amyotrophic lateral sclerosis Transcend Therapeutics, Inc.;640 Memorial Drive, 3rd Floor West;Cambridge, Massachusetts, 02139 July 30, 1996
Gusperimus Acute renal graft rejection episodes Bristol-Myers Squibb Pharmaceutical Research Institute;5 Research Parkway, P.O. Box 5100;Wallingford, Connecticut, 06492 June 27, 1996
Amphotericin B lipid complex Invasive candidiasis The Liposome Company, Inc.;One Research Way;Princeton, New Jersey, 08540 June 27, 1996